Baseline characteristics for the modified intent-to-treat (mITT) population.
| mITT Population, N = 14 | |
|---|---|
| Age, mean (SD), yrs | 49.3 (8.7) |
| Male sex, n (%) | 14 (100) |
| Race, n (%) | |
| White | 11 (78.6) |
| Black | 0 (0) |
| Asian | 2 (14.3) |
| Native Hawaiian or other Pacific Islander | 0 (0) |
| Other | 1 (7.1) |
| BMI, kg/m2, mean (SD) | 33.9 (7.0) |
| eGFR, mL/min/1.73 m2, mean (SD) | 84.6 (21.7) |
| Gout characteristics | |
| Time since first gout diagnosis, yrs, mean (SD) | 13.8 (7.4) |
| No. gout flares in the 12 months prior to screening, mean (SD) | 10.8 (8.5) |
| History of tophi, n (%) | 12 (85.7) |
| Baseline serum uric acid, mg/dL, mean (SD) | 9.2 (2.5) |
| Smoking status, n (%) | |
| Never | 4 (28.6) |
| Current | 5 (35.7) |
| Former | 5 (35.7) |
eGFR: estimated glomerular filtration rate; mITT: modified intent-to-treat.